Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: AN2 Therapeutics Inc., 3 years.
AN2 Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AN2 Therapeutics Inc. May 22, 202553.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | AN2 Therapeutics Inc. | Gift | −405,880 | — | — |
| Apr 10, 2025 | AN2 Therapeutics Inc. | Grant or award | +10,523 | — | — |
| Dec 19, 2024 | AN2 Therapeutics Inc. | Grant or award | +9,816 | — | — |
| Nov 27, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +2,000 | $1.40 | $2,800 |
| Nov 19, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +5,000 | $1.01 | $5,050 |
| Nov 18, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +20,000 | $1.00 | $20,000 |
| Jan 18, 2024 | AN2 Therapeutics Inc. | Open-market sale | −100,000 | $19.11 | $1,911,000 |
Questions about Joseph S. Zakrzewski
What boards is Joseph S. Zakrzewski on?
Joseph S. Zakrzewski sits on the board of AN2 Therapeutics Inc.
How long has Joseph S. Zakrzewski served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.